M Rossetti, H Guenard and C Gabinski
Laboratoire de Physiologie, Faculte Victor Pachon, Universite de Bordeaux, France.

The pulmonary vasculature site of action of nitric oxide (NO) in patients with acute respiratory distress syndrome (ARDS) is still unknown. Seven patients were studied during the early stage of ARDS. The bedside pulmonary artery single-occlusion technique, which allows estimation of the pulmonary capillary pressure (Pcap) and segmental pulmonary vascular resistance, was used without NO or with increasing inhaled NO concentrations (15 and 25 parts per million [ppm]). Systemic circulatory parameters remained unaltered during 15 ppm NO inhalation, whereas 25 ppm NO inhalation slightly decreased mean systemic arterial pressure from 76.7 +/- 5.1 (mean +/- SEM) to 69 +/- 5.2 mm Hg (p < 0.01). Mean pulmonary arterial pressure (Ppam) and mean pulmonary capillary pressure (Pcapm) fell during 25 ppm NO inhalation from 27.4 +/- 3.5 to 21 +/- 2.2 mm Hg (p < 0.001) and from 14.8 +/- 1.5 to 10.7 +/- 1.4 mm Hg (p < 0.001) respectively, the total pulmonary resistance decreased by 28% (p < 0.01). The resistance of the capillary-venous compartment fell during 25 ppm NO inhalation from 100 +/- 16 to 47 +/- 16 dyn x s x m(2) x cm(-5) (p < 0.01), whereas the pulmonary arterial resistance was unchanged. In these patients NO inhalation during the early stage of ARDS reduces selectively Ppam and Pcapm by decreasing the pulmonary capillary-venous resistance. This latter effect may reduce the filtration through the capillary bed and hence alveolar edema during ARDS.

This article has been cited by other articles:

				P. Fesler, A. Pagnamenta, J-L. Vachiery, S. Brimioulle, S. Abdel Kafi, A. Boonstra, M. Delcroix, R.N. Channick, L.J. Rubin, and R. Naeije Single arterial occlusion to locate resistance in patients with pulmonary hypertension Eur. Respir. J., January 1, 2003; 21(1): 31 - 36. [Abstract] [Full Text] [PDF]

				J. S. Young, C. S. Rayhrer, T. D. Edmisten, G. A. Cephas, C. G. Tribble, and I. L. Kron Sodium nitroprusside mitigates oleic acid-induced acute lung injury Ann. Thorac. Surg., January 1, 2000; 69(1): 224 - 227. [Abstract] [Full Text] [PDF]

				S. BHORADE, J. CHRISTENSON, M. O'CONNOR, A. LAVOIE, A. POHLMAN, and J. B. HALL Response to Inhaled Nitric Oxide in Patients with Acute Right Heart Syndrome Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 571 - 579. [Abstract] [Full Text]

				F. HINDER, H. D. STUBBE, H. VAN AKEN, R. WAURICK, M. BOOKE, and J. MEYER Role of Nitric Oxide in Sepsis-associated Pulmonary Edema Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 252 - 257. [Abstract] [Full Text]

				B. R. JACOBS, R. J. BRILLI, E. T. BALLARD, D. J. PASSERINI, and D. J. SMITH Aerosolized Soluble Nitric Oxide Donor Improves Oxygenation and Pulmonary Hypertension in Acute Lung Injury Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1536 - 1542. [Abstract] [Full Text] [PDF]

				C. S. Rayhrer, T. D. Edmisten, G. A. Cephas, C. G. Tribble, I. L. Kron, and J. S. Young Nitric Oxide Potentiates Acute Lung Injury in an Isolated Rabbit Lung Model Ann. Thorac. Surg., April 1, 1998; 65(4): 935 - 938. [Abstract] [Full Text] [PDF]

				W. S. Cruz, M. A. Moxley, J. A. Corbett, and W. J. Longmore Inhibition of nitric oxide synthase attenuates NNMU-induced alveolar injury in vivo Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1167 - L1173. [Abstract] [Full Text] [PDF]